View Author
vegfr expression liver tumor tumour growth tissue factor astrocytoma hepatocellular carcinoma pilocytic activity protein vegfr -2 cancer angiogenic level carcinoma study receptor angiogenesi kinase 0.0 hepatocellular cirrhotic endothelium pilocytic astrocytoma phosphorylation paediatric pilocytic astrocytoma growth factor cirrhotic livers authors neuropathology analysis sample antibody noncirrhotic kinase activity angiopoietin ang -2 hepatology staining vessel vegf-a vasculature therapy peptide uea 1 vegfr -2 expression assay treatment tumours paediatric noncirrhotic livers section © 2011 proximity neuropathology ligation author bevacizumab neurobiology rt-pcr enrichment blot analysis status kidney tyrosine tumour endothelium result 538–548 phosphorylated vegfr -2 pvegfr -2 neuropathological british phosphorylated society signi protein expression tie -2 glioblastoma
2 Most Recent Publications
|
Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells
(Article)
Sikkema, A.H. Bont, E.S.J.M. de Molema, G. Dimberg, A. Zwiers, P.J. Diks, S.H. Hoving, E.W. Kamps, W.A. Peppelenbosch, M.P. Dunnen, W.F.A. den |
2011-08-01
|
|
The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization
(Article)
Zeng, W. Gouw, A.S.H. Heuvel, M.C. van den Zwiers, P.J. Zondervan, P.E. Poppema, S. Zhang, N. Platteel, I. Jong, K.P. de Molema, G. |
2008-11-01
|